$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000142833618000017 Filed on June 07, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$69.90M	$55.42M
YoY Change	26.13%	25.92%
Cost Of Revenue	$25.55M	$21.68M
YoY Change	17.84%	32.75%
Gross Profit	$44.36M	$33.74M
YoY Change	31.46%	21.89%
Gross Profit Margin	63.45%	60.88%
Selling, General & Admin	$14.37M	$10.49M
YoY Change	36.97%	19.78%
% of Gross Profit	32.39%	31.09%
Research & Development	$7.979M	$6.242M
YoY Change	27.83%	34.96%
% of Gross Profit	17.99%	18.5%
Depreciation & Amortization	$4.520M	$3.482M
YoY Change	29.81%	18.15%
% of Gross Profit	10.19%	10.32%
Operating Expenses	$23.82M	$17.81M
YoY Change	33.69%	23.44%
Operating Profit	$20.54M	$15.93M
YoY Change	28.96%	20.2%
Interest Expense	$200.0K
YoY Change
% of Operating Profit	0.97%
Other Income/Expense, Net	-$1.000K	-$90.00K
YoY Change	-98.89%	-85.96%
Pretax Income	$20.54M	$15.84M
YoY Change	29.69%	25.6%
Income Tax	-$2.038M	$1.808M
% Of Pretax Income	-9.92%	11.42%
Net Earnings	$22.58M	$14.03M
YoY Change	60.93%	73.78%
Net Earnings / Revenue	32.3%	25.31%
Basic Earnings Per Share	$0.37	$0.23
Diluted Earnings Per Share	$0.36	$0.23
COMMON SHARES
Basic Shares Outstanding	61.17M shares	59.72M shares
Diluted Shares Outstanding	62.69M shares	61.40M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$269.8M	$195.6M
YoY Change	37.93%	47.18%
Cash & Equivalents	$228.9M	$155.1M
Short-Term Investments	$40.90M	$40.50M
Other Short-Term Assets	$10.73M	$4.100M
YoY Change	161.71%	-34.92%
Inventory	$177.0K	$529.0K
Prepaid Expenses		$4.069M
Receivables	$23.02M	$18.99M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$303.8M	$219.1M
YoY Change	38.61%	40.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.626M	$6.083M
YoY Change	41.81%	79.55%
Goodwill	$4.651M	$4.651M
YoY Change	0.0%	0.0%
Intangibles	$82.15M	$64.68M
YoY Change	27.0%	-2.67%
Long-Term Investments	$100.0K	$206.0K
YoY Change	-51.46%	-26.69%
Other Assets	$18.23M	$1.851M
YoY Change	884.66%	-1.23%
Total Long-Term Assets	$114.3M	$83.71M
YoY Change	36.51%	9.12%
TOTAL ASSETS
Total Short-Term Assets	$303.8M	$219.1M
Total Long-Term Assets	$114.3M	$83.71M
Total Assets	$418.0M	$302.8M
YoY Change	38.03%	30.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.112M	$1.545M
YoY Change	101.42%	26.02%
Accrued Expenses	$6.402M	$4.435M
YoY Change	44.35%	40.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.15M	$10.31M
YoY Change	66.46%	47.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.500M	$1.700M
YoY Change	47.06%	112.5%
Total Long-Term Liabilities	$3.903M	$1.700M
YoY Change	129.59%	-32.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.15M	$10.31M
Total Long-Term Liabilities	$3.903M	$1.700M
Total Liabilities	$21.06M	$12.01M
YoY Change	75.4%	26.3%
SHAREHOLDERS EQUITY
Retained Earnings	$120.5M	$52.08M
YoY Change	131.45%	345.78%
Common Stock	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$397.0M	$290.8M
YoY Change
Total Liabilities & Shareholders Equity	$418.0M	$302.8M
YoY Change	38.03%	30.4%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$22.58M	$14.03M
YoY Change	60.93%	73.78%
Depreciation, Depletion And Amortization	$4.520M	$3.482M
YoY Change	29.81%	18.15%
Cash From Operating Activities	$22.70M	$15.58M
YoY Change	45.76%	637.5%
INVESTING ACTIVITIES
Capital Expenditures	$1.121M	$1.437M
YoY Change	-21.99%	347.66%
Acquisitions
YoY Change
Other Investing Activities	-$200.0K	-$100.0K
YoY Change	100.0%	0.0%
Cash From Investing Activities	-$3.398M	-$4.274M
YoY Change	-20.5%	77.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$10.17M	$3.829M
YoY Change	165.53%	-59.37%
NET CHANGE
Cash From Operating Activities	$22.70M	$15.58M
Cash From Investing Activities	-$3.398M	-$4.274M
Cash From Financing Activities	$10.17M	$3.829M
Net Change In Cash	$29.47M	$15.13M
YoY Change	94.79%	65.82%
FREE CASH FLOW
Cash From Operating Activities	$22.70M	$15.58M
Capital Expenditures	$1.121M	$1.437M
Free Cash Flow	$21.58M	$14.14M
YoY Change	52.65%	689.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q2	dei	Amendment Flag AmendmentFlag	false
CY2018Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2018Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2018Q2	dei	Document Period End Date DocumentPeriodEndDate	2018-04-30
CY2018Q2	dei	Document Type DocumentType	10-Q
CY2018Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62046047	shares
CY2018Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q2	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2017Q2	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1083000	USD
CY2018Q2	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1470000	USD
CY2018Q1	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	240269000	USD
CY2018Q2	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	269835000	USD
CY2018Q2	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.02
CY2017Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	3304000	USD
CY2018Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	4062000	USD
CY2017Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	2801000	USD
CY2018Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	3439000	USD
CY2017Q2	hqy	Exerciseof Stock Options Receivable ExerciseofStockOptionsReceivable	0	USD
CY2018Q2	hqy	Exerciseof Stock Options Receivable ExerciseofStockOptionsReceivable	797000	USD
CY2017Q2	hqy	Marketable Securities Unrealized Gain Loss And Other Noncash Income Expense MarketableSecuritiesUnrealizedGainLossAndOtherNoncashIncomeExpense	-41000	USD
CY2018Q2	hqy	Marketable Securities Unrealized Gain Loss And Other Noncash Income Expense MarketableSecuritiesUnrealizedGainLossAndOtherNoncashIncomeExpense	-102000	USD
CY2017Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	100000	USD
CY2018Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	100000	USD
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	14.00
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted	50.41
CY2018Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	44.53
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	44.53
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted	61.72
CY2018Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	51.44
CY2018Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	61.72
CY2018Q2	hqy	Sharebased Compensation Arrangementby Sharebased Payment Award Additional Shares Availablefor Grants Percentageof Capital Stock Outstanding Percentage SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage	0.03
CY2018	hqy	Tax Cuts And Jobs Actof2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActof2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	500000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2420000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3112000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21602000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23022000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5521000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6402000	USD
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7415000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7654000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-269000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	261237000	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	276440000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3010000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4239000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	208000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	229000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2800000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3700000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2018Q1	us-gaap	Assets Assets	369159000	USD
CY2018Q2	us-gaap	Assets Assets	418031000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	265396000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	303764000	USD
CY2018Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40797000	USD
CY2018Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40890000	USD
CY2018Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	270000	USD
CY2018Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	286000	USD
CY2018Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	626000	USD
CY2018Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	730000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15567000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15232000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	40890000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	41334000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	25767000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	25658000	USD
CY2017Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	133000	USD
CY2018Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	491000	USD
CY2017Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2200000	USD
CY2018Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2100000	USD
CY2018Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	17500000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139954000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155085000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199472000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	228945000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	199472000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	228945000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15131000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	29473000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	240625000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	270279000	USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	127653000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	124611000	USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60825000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61788000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60825000	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61788000	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2018Q2	us-gaap	Cost Method Investments CostMethodInvestments	500000	USD
CY2017Q2	us-gaap	Cost Of Services CostOfServices	21680000	USD
CY2018Q2	us-gaap	Cost Of Services CostOfServices	25548000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5461000	USD
CY2018Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	616000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1274000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3218000	USD
CY2018Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1989000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2018Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1437000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18000	USD
CY2018Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2395000	USD
CY2018Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2466000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	600000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	800000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3482000	USD
CY2018Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4520000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.114
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.099
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.248
CY2018Q2	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.318
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12549000	USD
CY2018Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7640000	USD
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	16800000	USD
CY2018Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.22
CY2018Q2	us-gaap	Equity Method Investments EquityMethodInvestments	100000	USD
CY2017Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	13615000	USD
CY2018Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	16649000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	44018000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	42463000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17154000	USD
CY2018Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2395000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83635000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82148000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5868000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7507000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	4651000	USD
CY2017Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2018Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	33741000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	44356000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15837000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20539000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1808000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2038000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1545000	USD
CY2018Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	87000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1987000	USD
CY2018Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1420000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	625000	USD
CY2018Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	881000	USD
CY2017Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4397000	USD
CY2018Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4909000	USD
CY2017Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-63000	USD
CY2018Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-38000	USD
CY2017Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	244000	USD
CY2018Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	71000	USD
CY2017Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1207000	USD
CY2018Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5471000	USD
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1680000	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1523000	shares
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83635000	USD
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	82148000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	215000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	177000	USD
CY2017Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	19319000	USD
CY2018Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	28434000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000	USD
CY2018Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1300000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	22885000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	21057000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	369159000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	418031000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20490000	USD
CY2018Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3903000	USD
CY2018Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-100000	USD
CY2017Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	22487000	USD
CY2018Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	24821000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3829000	USD
CY2018Q2	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	117000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-90000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	17814000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	23816000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15927000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	20540000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3310000	USD
CY2018Q2	us-gaap	Other Assets Current OtherAssetsCurrent	10730000	USD
CY2018Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10167000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4274000	USD
CY2018Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3398000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15576000	USD
CY2018Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22704000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	14029000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	22577000	USD
CY2017Q2	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	141000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4676000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2180000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18226000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18027000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-26000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14003000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22577000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	USD
CY2017Q2	us-gaap	Payments For Software PaymentsForSoftware	2728000	USD
CY2018Q2	us-gaap	Payments For Software PaymentsForSoftware	2097000	USD
CY2017Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	109000	USD
CY2018Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	180000	USD
CY2017Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1437000	USD
CY2018Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1121000	USD
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3829000	USD
CY2018Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10167000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15251000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16280000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7836000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8626000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6242000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7979000	USD
CY2017Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2800000	USD
CY2018Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	3200000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	85300000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	120528000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	98308000	USD
CY2018Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	500000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	700000	USD
CY2017Q2	us-gaap	Revenues Revenues	55421000	USD
CY2018Q2	us-gaap	Revenues Revenues	69904000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4621000	USD
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6860000	USD
CY2017Q2	us-gaap	Service Management Costs ServiceManagementCosts	15575000	USD
CY2018Q2	us-gaap	Service Management Costs ServiceManagementCosts	18047000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3010000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4239000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3784
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3801
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3790
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0207
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0268
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0190
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0252
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2600000.0	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	19.39
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	29.34
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	87000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	89000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	102796000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	123162000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3699000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3038000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.83
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.12
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	123162000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1171000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3038000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	25.12
CY2018Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.53
CY2018Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	60.07
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	54186000	USD
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M5D
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M20D
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M20D
CY2018Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	663000	shares
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	346274000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	396974000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000	USD
CY2018Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	900000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61400000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62693000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59720000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61170000	shares

Files In Submission

Name	View Source	Status
0001428336-18-000017-index-headers.html	Edgar Link	pending
0001428336-18-000017-index.html	Edgar Link	pending
0001428336-18-000017.txt	Edgar Link	pending
0001428336-18-000017-xbrl.zip	Edgar Link	pending
a101-hillangelique.htm	Edgar Link	pending
a102-hillangeliquenonxcomp.htm	Edgar Link	pending
exhibit311-ceo302x0430.htm	Edgar Link	pending
exhibit312-cfo302x0430.htm	Edgar Link	pending
exhibit321-ceo906x0430.htm	Edgar Link	pending
exhibit322-cfo906x0430.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hillangeliqueevpofope_image1.gif	Edgar Link	pending
hqy-20180430.xml	Edgar Link	completed
hqy-20180430.xsd	Edgar Link	pending
hqy-20180430_cal.xml	Edgar Link	unprocessable
hqy-20180430_def.xml	Edgar Link	unprocessable
hqy-20180430_lab.xml	Edgar Link	unprocessable
hqy-20180430_pre.xml	Edgar Link	unprocessable
hqy-2018x4x3010q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2018 Q2 Form 10-Q Financial Statement

#000142833618000017 Filed on June 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2018 Q2 Form 10-Q Financial Statement

#000142833618000017 Filed on June 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy